摘要
目的探讨药学服务对稳定期COPD患者用药依从性和肺功能的影响,为后续建立慢病管理药学服务模式提供可行的方法和依据。方法选取某院药物咨询室2016年4月~2017年4月期间40例稳定期COPD患者,随机分成对照组和观察组,其中观察组予以药学服务干预,对照组不作干预。半年内每月定期进行药学随访。结果观察组对COPD认知程度的良好性优于对照组,组间比较P(0.004)<0.05;用药依从性方面,观察组较干预前有显著提高P(0.031)<0.05,对照组干预前后无显著改变P(0.744)>0.05;肺功能方面,观察组干预前后肺功能无显著差异,FEV1%前后比较P(0.223)>0.05,FEV1/FVC%前后比较P(0.110)>0.05,优于对照组。结论药学服务能有效增进稳定期COPD患者对疾病治疗与预防的了解,提高患者的用药依从性,促进合理用药,延缓肺功能减退。
OBJECTIVE To investigate the effects of pharmaceutical service on compliance and lung function in patients with stable COPD, so as to provide a feasible way and basis to establish a pharmaceutical service model for chronic disease management. METHODS Forty patients with stable COPD were enrolled in a drug consultation room from April 2016 to April 2017, which were randomly divided into observation group or control group. The observation group received pharmaceutical service whereas the control group did not. Regular follow-up was performed in both groups monthly for half year. RESULTS The observation group had better awareness of COPD than the control group[ P( 0.004)<0.05 ]. The compliance improved significantly in observation group[ P( 0.031 )< 0.05], but not in control group [ P( 0.744)>0.05]. Refer to the lung function, the change of FEV1% and FEV1/FVC% were not observed in observation group [ P ( 0. 223 )> 0. 05, P ( 0. 110 )> 0. 05 respectively ], which was better than the control group. CONCLUSION Pharmaceutical service can improve the awareness of disease control in stable COPD patients, increase compliance and reasonable drug use, and delay the time of lung dysfunction.
作者
朱健恩
王志鹏
魏理
ZHU Jianen;WANG Zhipeng;WEI Li(Department of pharmacy, The First Affiliated Hospital Of Guangzhou Medical University,Guangzhou, Guangdong 510120,China)
出处
《今日药学》
CAS
2019年第6期413-415,426,共4页
Pharmacy Today
关键词
COPD
药学服务
依从性
肺功能
COPD
pharmaceutical service
compliance
lung function
